Joseph Andrew Rosenthal, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bacterial Vaccines | 2 | 2016 | 420 | 0.570 |
Why?
|
Bacterial Outer Membrane Proteins | 2 | 2016 | 400 | 0.570 |
Why?
|
Antibodies, Bacterial | 3 | 2016 | 1446 | 0.540 |
Why?
|
Vaccines, Virus-Like Particle | 1 | 2013 | 34 | 0.510 |
Why?
|
Antigens, Bacterial | 2 | 2016 | 1192 | 0.440 |
Why?
|
Fatigue | 2 | 2016 | 1450 | 0.440 |
Why?
|
Blindness, Cortical | 1 | 2011 | 16 | 0.430 |
Why?
|
Autonomic Dysreflexia | 1 | 2011 | 14 | 0.420 |
Why?
|
Quadriplegia | 1 | 2011 | 184 | 0.380 |
Why?
|
Th1 Cells | 1 | 2014 | 1082 | 0.370 |
Why?
|
Drug Carriers | 1 | 2013 | 715 | 0.350 |
Why?
|
Sports | 1 | 2014 | 652 | 0.340 |
Why?
|
Models, Neurological | 1 | 2016 | 1770 | 0.330 |
Why?
|
Athletes | 1 | 2014 | 1038 | 0.290 |
Why?
|
Vaccines | 1 | 2013 | 719 | 0.290 |
Why?
|
Students | 1 | 2014 | 1562 | 0.260 |
Why?
|
Athletic Injuries | 1 | 2014 | 1132 | 0.250 |
Why?
|
Seizures | 1 | 2016 | 2562 | 0.250 |
Why?
|
Brain Ischemia | 3 | 2022 | 3260 | 0.240 |
Why?
|
Escherichia coli | 2 | 2016 | 4316 | 0.240 |
Why?
|
Population Surveillance | 1 | 2014 | 2606 | 0.240 |
Why?
|
Nanoparticles | 1 | 2013 | 2048 | 0.210 |
Why?
|
Vaccines, Synthetic | 2 | 2014 | 629 | 0.210 |
Why?
|
Law Enforcement | 1 | 2021 | 102 | 0.190 |
Why?
|
Restraint, Physical | 1 | 2021 | 183 | 0.190 |
Why?
|
Accidental Falls | 2 | 2016 | 1025 | 0.170 |
Why?
|
Endovascular Procedures | 2 | 2022 | 1959 | 0.170 |
Why?
|
Neisseria meningitidis, Serogroup B | 1 | 2016 | 7 | 0.160 |
Why?
|
Epilepsy, Post-Traumatic | 1 | 2016 | 36 | 0.150 |
Why?
|
Hospitalization | 1 | 2016 | 9644 | 0.150 |
Why?
|
Tularemia | 1 | 2016 | 33 | 0.150 |
Why?
|
Carotid Arteries | 1 | 2021 | 977 | 0.150 |
Why?
|
Francisella tularensis | 1 | 2016 | 55 | 0.150 |
Why?
|
Transport Vesicles | 1 | 2016 | 89 | 0.140 |
Why?
|
Sensation Disorders | 1 | 2016 | 158 | 0.140 |
Why?
|
Stroke | 3 | 2022 | 9256 | 0.140 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2016 | 184 | 0.140 |
Why?
|
Hemolysin Proteins | 1 | 2014 | 113 | 0.130 |
Why?
|
Immunoglobulin Class Switching | 1 | 2016 | 294 | 0.130 |
Why?
|
Vaccines, Subunit | 1 | 2014 | 143 | 0.130 |
Why?
|
Cell Membrane | 2 | 2014 | 3892 | 0.130 |
Why?
|
Immunization | 2 | 2016 | 1273 | 0.120 |
Why?
|
Physician's Role | 1 | 2021 | 982 | 0.120 |
Why?
|
Brain Injuries | 2 | 2015 | 1909 | 0.120 |
Why?
|
Psychomotor Agitation | 1 | 2015 | 274 | 0.120 |
Why?
|
Motor Cortex | 1 | 2020 | 957 | 0.120 |
Why?
|
Blood Transfusion | 1 | 2018 | 1246 | 0.120 |
Why?
|
Biomimetics | 1 | 2013 | 168 | 0.110 |
Why?
|
Thrombectomy | 3 | 2022 | 673 | 0.110 |
Why?
|
Craniotomy | 1 | 2016 | 727 | 0.110 |
Why?
|
Craniocerebral Trauma | 1 | 2016 | 474 | 0.110 |
Why?
|
Mice, Inbred BALB C | 3 | 2016 | 6684 | 0.110 |
Why?
|
Postural Balance | 1 | 2016 | 635 | 0.110 |
Why?
|
Probiotics | 1 | 2014 | 339 | 0.100 |
Why?
|
International Classification of Diseases | 1 | 2016 | 844 | 0.100 |
Why?
|
Remission Induction | 1 | 2016 | 2399 | 0.100 |
Why?
|
Epidemiologic Studies | 1 | 2014 | 614 | 0.100 |
Why?
|
Cerebrovascular Circulation | 1 | 2021 | 2748 | 0.100 |
Why?
|
Immunity, Humoral | 1 | 2014 | 579 | 0.100 |
Why?
|
Bone Marrow Transplantation | 1 | 2018 | 2789 | 0.100 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2020 | 1345 | 0.100 |
Why?
|
Species Specificity | 1 | 2014 | 2619 | 0.100 |
Why?
|
Triage | 1 | 2016 | 913 | 0.090 |
Why?
|
Epitopes | 1 | 2016 | 2646 | 0.090 |
Why?
|
Polysaccharides | 1 | 2016 | 991 | 0.090 |
Why?
|
Geriatric Assessment | 1 | 2016 | 1309 | 0.090 |
Why?
|
Adjuvants, Immunologic | 1 | 2013 | 954 | 0.090 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1693 | 0.090 |
Why?
|
Inpatients | 2 | 2015 | 2207 | 0.080 |
Why?
|
Escherichia coli Proteins | 1 | 2014 | 1080 | 0.080 |
Why?
|
Longitudinal Studies | 3 | 2016 | 13536 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 1 | 2014 | 3878 | 0.070 |
Why?
|
Schools | 1 | 2014 | 1361 | 0.070 |
Why?
|
Biocompatible Materials | 1 | 2013 | 1725 | 0.070 |
Why?
|
Male | 13 | 2022 | 349524 | 0.070 |
Why?
|
Female | 15 | 2022 | 375205 | 0.060 |
Why?
|
Rehabilitation Centers | 2 | 2015 | 243 | 0.060 |
Why?
|
Magnetic Resonance Angiography | 1 | 2011 | 1481 | 0.060 |
Why?
|
Canada | 2 | 2021 | 1915 | 0.060 |
Why?
|
Young Adult | 4 | 2018 | 55940 | 0.060 |
Why?
|
Bacteria | 1 | 2014 | 2040 | 0.060 |
Why?
|
Brain Concussion | 1 | 2014 | 1288 | 0.060 |
Why?
|
Adult | 8 | 2021 | 211041 | 0.060 |
Why?
|
Humans | 19 | 2022 | 708843 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 3 | 2022 | 34151 | 0.050 |
Why?
|
Anxiety | 1 | 2015 | 3887 | 0.050 |
Why?
|
Gene Expression | 1 | 2014 | 8014 | 0.050 |
Why?
|
Logistic Models | 1 | 2016 | 13468 | 0.050 |
Why?
|
Adolescent | 4 | 2018 | 84718 | 0.050 |
Why?
|
Reperfusion | 1 | 2021 | 290 | 0.050 |
Why?
|
Depression | 2 | 2016 | 7202 | 0.050 |
Why?
|
Emergency Service, Hospital | 2 | 2016 | 7428 | 0.050 |
Why?
|
Risk Factors | 5 | 2018 | 69553 | 0.050 |
Why?
|
Radiography | 1 | 2011 | 6989 | 0.050 |
Why?
|
Middle Aged | 6 | 2022 | 213752 | 0.050 |
Why?
|
Aged | 7 | 2022 | 161488 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39038 | 0.040 |
Why?
|
Time Factors | 2 | 2016 | 41038 | 0.040 |
Why?
|
Antigen-Antibody Reactions | 1 | 2016 | 412 | 0.040 |
Why?
|
Neck | 1 | 2021 | 698 | 0.040 |
Why?
|
United States | 4 | 2021 | 67165 | 0.040 |
Why?
|
Prognosis | 1 | 2016 | 28919 | 0.040 |
Why?
|
O Antigens | 1 | 2016 | 168 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 2021 | 1306 | 0.030 |
Why?
|
Mice | 3 | 2016 | 80876 | 0.030 |
Why?
|
Trauma Severity Indices | 1 | 2015 | 488 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2022 | 61932 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58184 | 0.030 |
Why?
|
Prospective Studies | 4 | 2021 | 50597 | 0.030 |
Why?
|
Bioengineering | 1 | 2014 | 106 | 0.030 |
Why?
|
Glycosylation | 1 | 2016 | 1127 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2015 | 987 | 0.030 |
Why?
|
Age Factors | 2 | 2021 | 18712 | 0.030 |
Why?
|
Age of Onset | 1 | 2018 | 3330 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2022 | 71483 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2021 | 2163 | 0.030 |
Why?
|
Trauma Centers | 1 | 2016 | 837 | 0.030 |
Why?
|
Animals | 4 | 2016 | 170486 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2945 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4831 | 0.020 |
Why?
|
Cerebral Hemorrhage | 1 | 2021 | 2518 | 0.020 |
Why?
|
Biological Transport | 1 | 2014 | 2146 | 0.020 |
Why?
|
Incidence | 2 | 2018 | 20320 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2018 | 1687 | 0.020 |
Why?
|
Exercise Therapy | 1 | 2014 | 901 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2018 | 2818 | 0.020 |
Why?
|
Cohort Studies | 2 | 2018 | 39292 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5986 | 0.020 |
Why?
|
Vaccination | 1 | 2016 | 2864 | 0.020 |
Why?
|
Brain | 1 | 2011 | 24969 | 0.020 |
Why?
|
Survival Rate | 1 | 2018 | 13202 | 0.020 |
Why?
|
Pilot Projects | 1 | 2016 | 7994 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5135 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 14712 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 24433 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7487 | 0.010 |
Why?
|
Infant | 1 | 2018 | 34261 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 41081 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23284 | 0.010 |
Why?
|
Child | 1 | 2018 | 73636 | 0.010 |
Why?
|